feedback

Faculty

Christos Tziotzios, MA, MB BChir (Cantab), MRCP (UK)

St. John's Institute of Dermatology, King's College London, Guy's Hospital, London, United Kingdom

Timothy Brier, MBBS, MRCP (UK)

St. John's Institute of Dermatology, King's College London, Guy's Hospital, London, United Kingdom

John Y.W. Lee, BSc

St. John's Institute of Dermatology, King's College London, Guy's Hospital, London, United Kingdom

Ryo Saito, MD

St. John's Institute of Dermatology, King's College London, Guy's Hospital, London, United Kingdom

Chao-Kai Hsu, MD

St. John's Institute of Dermatology, King's College London, Guy's Hospital, London, United Kingdom

Catherine M. Stefanato, MD, FRCPath

Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas' Hospital, London, United Kingdom

Kapil Bhargava, MBBS, MRCP (UK)

St. John's Institute of Dermatology, King's College London, Guy's Hospital, London, United Kingdom

David A. Fenton, FRCP, MBE

St. John's Institute of Dermatology, King's College London, Guy's Hospital, London, United Kingdom

John A. McGrath, MD, FRCP, FMedSci

St. John's Institute of Dermatology, King's College London, Guy's Hospital, London, United Kingdom

Accredited by

American Academy of Dermatology

Course Description

Having reviewed the diverse clinical subtypes of lichenoid disease and the postulated molecular basis thereof in the first article in this 2-part continuing medical education series, we discuss herein the existing and emerging treatment strategies in the most common clinical forms of lichenoid inflammation and provide an overview of their pharmacodynamics and evidence base. The scope of this review is not to exhaustively discuss treatment modalities for all lichenoid variants discussed in the previous article of this series. Instead, the focus will be on frequently encountered subtypes of lichen planus and on linking mechanisms of disease with mechanisms of drug action. Future directions and potential avenues for translational research will also be discussed.

Activity Details

Credit Types:CME / MOC
Credit Amount:1.00 Credits
Release Date:2018-Nov-01
Expiration Date:2021-Nov-01
Estimated Time for Completion:1 hour
Registration Required:Yes
Cost:$0.00-$39.95
System Requirements:
CME is free with premium AAD membership.
CME can be purchased individually for $35.95.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.